Powered by
-
PFE Stock Chart
Historical PFE Prices
Pfizer Stock Analysis
Rating: Hold
Total Grade: C
Analysis Breakdown
| PFE Stock Grade: | C |
| Fundamental Grade: | B |
| Quantitative Grade: | D |
| PFE Earnings | |
| Earnings Growth: | A |
| Earnings Momentum: | A |
| Earnings Surprises: | C |
| Analyst Earnings Revisions: | C |
| PFE Financial Information | |
| Sales Growth: | D |
| Operating Margin Growth: | A |
| Cash Flow: | C |
| Return on Equity: | B |
Pfizer Stock: Weekly View
| This Week: | C |
|---|---|
| Last Week: | D |
| Two Weeks Ago: | D |
PFE Stock predictions, Articles, and Pfizer News
- From InvestorPlace
- From the Web
-
5 Blue-Chip Stocks That “Dow 23,000” Left in the Dust - October 18, 2017
These blue-chip stocks didn't follow in the footsteps of IBM's massive leap. Here's what you need to know about each in the wake of "Dow 23,000." Continue…
-
Dow Jones Industrial Average Hits 23,000. Now What? - October 18, 2017
The Dow Jones Industrial Average is definitely overbought. I wouldn't be a buyer, but staying long could have its advantages. Continue…
-
4 Blue-Chip Stocks to Sell and 4 Stocks to Buy Right Now - October 13, 2017
Don't suffer from little upside with these blue-chip stocks to sell, when you can have these stocks to buy with substantial growth potential. Continue…
-
Pfizer Inc. (PFE) May Spin Off Consumer Health Biz - October 10, 2017
Pfizer (PFE) is reportedly considering spinning off its consumer health brands. The combination of these brands is worth about $15 billion. Continue…
-
10 Best Stocks to Buy and Hold for the Next Decade - October 10, 2017
These are some of the best stocks to buy if you're looking for long-term potential. Here's what you need to know about each. Continue…
-
Going Long Pfizer Inc. (PFE) Stock Is an Easy Pill to Swallow - October 10, 2017
Momentum rallies are often a show of good support. Bet on Pfizer (PFE ) stock's proven levels to hold for at least six months. Continue…
-
Pfizer (PFE) Sell Ranking Confirmed - October 6, 2017
Pfizer Inc (NYSE:PFE) is ranked as a Sell using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking PFE has had from Portfolio Grader for the last month. Continue…
-
Gilead Sciences, Inc. (GILD) Stock Got Its Mojo Back - September 29, 2017
For a while GILD stock was a hideous knife to catch. But now that it reestablished its bottom, I can safely make money in Gilead. Continue…
-
3 Dividend Stocks to Buy and Hold Forever - September 27, 2017
Dividend and growth fanatics have argued tooth-and-nail about who backs the superior strategy for decades. But time and time again, deep research shows that inv... Continue…
-
Buy Bristol-Myers Squibb Co (BMY) Stock With No Fear - September 18, 2017
BMY is rallying on solid fundamentals to reclaim a long-term pivot levels as support for even higher prices. Go long on strong support. Continue…
